VL
| Investor | Type | Est. change | Change | Δ Own | Date | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Schwab
· Reduced
−$1.9B
Change
−9.0M
Date
Q1 2026
|
Schwab | Reduced· Q1 2026 | −$1.9B | −9.0M | – | Q1 2026 | |||||
|
Norges
· Exited
−$1.4B
Change
−6.8M
Δ Own
−100.0%
Date
Q1 2026
|
Norges | Exited· Q1 2026 | −$1.4B | −6.8M | −100.0% | Q1 2026 | |||||
|
T. Rowe Price Associates
· Reduced
−$390M
Change
−1.9M
Date
Q1 2026
|
T. Rowe Price Associates | Reduced· Q1 2026 | −$390M | −1.9M | – | Q1 2026 | |||||
|
FMR LLC
· Added
+$332M
Change
+1.6M
Δ Own
+23.8%
Date
Q1 2026
|
FMR LLC | Added· Q1 2026 | +$332M | +1.6M | +23.8% | Q1 2026 | |||||
|
State Street
· Added
+$297M
Change
+1.4M
Date
Q1 2026
|
State Street | Added· Q1 2026 | +$297M | +1.4M | – | Q1 2026 | |||||
|
JPMorgan Chase & Co
· Added
+$296M
Change
+1.4M
Date
Q1 2026
|
JPMorgan Chase & Co | Added· Q1 2026 | +$296M | +1.4M | – | Q1 2026 | |||||
|
Millennium Management LLC
· Added
+$264M
Change
+1.3M
Date
Q1 2026
|
Millennium Management LLC | Added· Q1 2026 | +$264M | +1.3M | – | Q1 2026 | |||||
|
Two Sigma Advisers, LP
· Exited
−$222M
Change
−1.1M
Δ Own
−100.0%
Date
Q1 2026
|
Two Sigma Advisers, LP | Exited· Q1 2026 | −$222M | −1.1M | −100.0% | Q1 2026 | |||||
|
Wellington Management Group LLP
· Reduced
−$211M
Change
−1.0M
Δ Own
−43.8%
Date
Q1 2026
|
Wellington Management Group LLP | Reduced· Q1 2026 | −$211M | −1.0M | −43.8% | Q1 2026 | |||||
|
Ameriprise Financial Inc
· Added
+$189M
Change
+917K
Date
Q1 2026
|
Ameriprise Financial Inc | Added· Q1 2026 | +$189M | +917K | – | Q1 2026 | |||||
|
Life Cycle Investment Partners Ltd
· Added
+$174M
Change
+843K
Date
Q1 2026
|
Life Cycle Investment Partners Ltd | Added· Q1 2026 | +$174M | +843K | – | Q1 2026 | |||||
|
Amundi
· Added
+$166M
Change
+806K
Date
Q1 2026
|
Amundi | Added· Q1 2026 | +$166M | +806K | – | Q1 2026 | |||||
|
Victory Capital Management Inc
· Reduced
−$164M
Change
−795K
Date
Q1 2026
|
Victory Capital Management Inc | Reduced· Q1 2026 | −$164M | −795K | – | Q1 2026 | |||||
|
Hrt Financial LP
· New
+$150M
Change
+726K
Date
Q1 2026
|
Hrt Financial LP | New· Q1 2026 | +$150M | +726K | – | Q1 2026 | |||||
|
Marshall Wace, LLP
· New
+$141M
Change
+682K
Date
Q1 2026
|
Marshall Wace, LLP | New· Q1 2026 | +$141M | +682K | – | Q1 2026 | |||||
| Insider | Title | Type | Price | Qty | Value | Owned | ΔOwn | Trade date | Filed date | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Fisher Eric A.
· Officer
Sell
−$2.0M
|
Fisher Eric A. | Officer | Sell | $268.17 | −8K | −$2.0M | 20K | −27.5% | Jun 29, 2026 | Jun 30, 2026 | |||||||||
|
Fisher Eric A.
· Officer
Sell
−$1.8M
|
Fisher Eric A. | Officer | Sell | $236.90 | −8K | −$1.8M | 27K | – | Jun 18, 2026 | Jun 18, 2026 | |||||||||
|
Fisher Eric A.
· Officer
Sell
−$1.9M
|
Fisher Eric A. | Officer | Sell | $251.61 | −8K | −$1.9M | 35K | – | May 18, 2026 | May 20, 2026 | |||||||||
|
Wilkins Rayford Jr
· Director
Grant (A)
939
|
Wilkins Rayford Jr | Director | Grant (A) | – | 939 | – | 939 | – | May 7, 2026 | May 11, 2026 | |||||||||
|
Weisenburger Randall J.
· Director
Grant (A)
939
|
Weisenburger Randall J. | Director | Grant (A) | – | 939 | – | 939 | – | May 7, 2026 | May 11, 2026 | |||||||||
|
Mullins Eric D.
· Director
Grant (A)
939
|
Mullins Eric D. | Director | Grant (A) | – | 939 | – | 939 | – | May 7, 2026 | May 11, 2026 | |||||||||
|
Majoras Deborah P.
· Director
Grant (A)
939
|
Majoras Deborah P. | Director | Grant (A) | – | 939 | – | 939 | – | May 7, 2026 | May 11, 2026 | |||||||||
|
Diaz Fred M.
· Director
Grant (A)
939
|
Diaz Fred M. | Director | Grant (A) | – | 939 | – | 939 | – | May 7, 2026 | May 11, 2026 | |||||||||
|
Greene Kimberly S,
· Director
Grant (A)
939
|
Greene Kimberly S, | Director | Grant (A) | – | 939 | – | 939 | – | May 7, 2026 | May 11, 2026 | |||||||||
|
Ffolkes Marie A.
· Director
Grant (A)
939
|
Ffolkes Marie A. | Director | Grant (A) | – | 939 | – | 939 | – | May 7, 2026 | May 11, 2026 | |||||||||
|
Eberhart Paulett
· Director
Grant (A)
939
|
Eberhart Paulett | Director | Grant (A) | – | 939 | – | 939 | – | May 7, 2026 | May 11, 2026 | |||||||||
|
Reymond Robert L.
· Director
Grant (A)
939
|
Reymond Robert L. | Director | Grant (A) | – | 939 | – | 939 | – | May 7, 2026 | May 11, 2026 | |||||||||
|
Wilkins Rayford Jr
· Director
2 operations
0
|
Wilkins Rayford Jr | Director | 2 operations | – | 0 | – | 0 | – | May 6, 2026 | May 7, 2026 | |||||||||
|
Wilkins Rayford Jr
· Director
Shares transferred outside the market (D), often for tax or as a gift, not a market sale
-$73K
|
Wilkins Rayford Jr | Director | Shares transferred outside the market (D), often for tax or as a gift, not a market sale | $239.26 | -304 | -$73K | 43K | – | May 6, 2026 | May 7, 2026 | |||||||||
|
Ffolkes Marie A.
· Director
2 operations
0
|
Ffolkes Marie A. | Director | 2 operations | – | 0 | – | 0 | – | May 6, 2026 | May 7, 2026 | |||||||||
1,690 reporting institutions disclosed VLO position changes in the Q1 2026 snapshot.
For each manager, WhoBought compares accepted consecutive 13F share counts. Share change is current shares minus prior shares. Estimated dollar change is that signed share change multiplied by the split-adjusted quarter-mean close. The activity table on this page uses Q1 2026.
An investor crossing 5% of a share class generally files Schedule 13D for activist intent or Schedule 13G for a passive position. The technical form names appear here rather than in the activity rows.
Ownership and institutional activity come from SEC Form 13F filings. Insider activity comes from SEC Form 4, and large-shareholder activity from SEC Schedules 13D and 13G. FMP supplies price data only. Company logos use the local verified Parqet cache with one shared fallback.
Form 13F is a quarterly disclosure and is normally filed after the quarter ends. Every ownership and activity value therefore names its represented period; it is not presented as a live position.
A muted dash marks a missing table value. It means the filing omitted the value, comparable data is unavailable, or no prior position exists for comparison.